AI for Pharma & Healthcare 2025

Meta analysis of preventing postoperative after non-cardiac surgery

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Philips, Masimo Extend Partnership to Sensor...

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series...

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

Herein, experts intended to gauge if pharmacologic prophylaxis reduced the incidence of post-operative atrial fibrillation after non-cardiac surgery.

Data exhibited that a reduction could be achieved in the incidence of postoperative atrial fibrillation through pharmacologic prophylaxis with amiodarone, beta-blockers, or statins. Furthermore, a relatively low overall risk of short-term adverse events was displayed by amiodarone and statins.

Methods
An electronic search was carried out of Ovid MEDLINE, the Cochrane central register of controlled trials database, and SCOPUS from inception to 9/7/2016.

Prospective randomized studies were included for this analysis in which patients in sinus rhythm underwent non-cardiac surgery.

Researchers assessed the incidence of post-operative atrial fibrillation as well as secondary safety outcomes.

Results
A total of 21 studies including 11,608 patients were analyzed.

The types of surgery consisted of vascular surgery (3,465 patients), thoracic surgery (2,757 patients), general surgery (2,292 patients), orthopedic surgery (1,756 patients), and other surgery (1,338 patients).

A reduction was achieved in the post-operative atrial fibrillation due to beta-blockers (RR 0.32; 95% CI 0.11 to 0.87), amiodarone (RR 0.42; 95% CI 0.26 to 0.67), and statins (RR 0.43; 95% CI 0.27 to 0.68) compared to placebo or active controls.

No statistically prominent effect was noted of the calcium channel blockers (RR 0.55; 95% CI
0.30 to 1.01), digoxin (RR 1.62; 95% CI 0.95 to 2.76), and magnesium (RR 0.73; 95% CI 0.23 to 2.33) on the post-operative atrial fibrillation incidence.

Findings illustrated comparable incidence of adverse events across agents, except for increased mortality (RR 1.33; 95% CI 1.03 to 1.37) and bradycardia (RR 2.74; 95% CI 2.19 to 3.43) in subjects receiving beta-blockers

Latest stories

Related stories

Philips, Masimo Extend Partnership to Sensor Technologies

Philips and Masimo have gone on to renew their...

Renovo from China Raises $67M Series D Funding by JJDC

Ronovo Surgical from China has gone on to close...

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »